Oct 27 (Reuters) – Orchestra Biomed Holdings Inc : * ORCHESTRA BIOMED ANNOUNCES FIRST PATIENTS ENROLLED IN VIRTUE® SAB US PIVOTAL IDE CORONARY TRIAL Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)